NCT03860272 2026-03-30Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerAgenus Inc.Phase 1 Active not recruiting499 enrolled
NCT05377528 2025-04-30Study of AGEN1571 in Participants With Advanced Solid TumorsAgenus Inc.Phase 1 Completed22 enrolled
NCT04156100 2022-03-03A Study in Subjects With Advanced Solid TumorsAgenus Inc.Phase 1 Terminated19 enrolled